Gianluca Gaidano

70PUBLICATIONS
579CO-AUTHORS
Predictive and prognostic markersRadiation therapyMajor global burdens of diseaseGene expression (incl. microarray and other genome-wide approaches)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (70)

|Jul 24, 2026
Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial.

|Jun 25, 2026
Renoir phase III Rituximab-Lenalidomide vs Rituximab as Maintenance Treatment in Relapsed/Refractory Follicular Lymphoma.

|May 27, 2026
Association Between Socioeconomic Inequalities and Health-Related Quality of Life in Patients With Relapsed/Refractory Multiple Myeloma.

|May 27, 2026
Integrated multiomic profiling reveals 2 distinct splenic marginal zone lymphoma subgroups with prognostic relevance.

|May 13, 2026
Molecular Mechanisms of Resistance to Bispecific Antibodies in Diffuse Large B-Cell Lymphoma.

|Apr 02, 2026
No lymphocytosis increase after cBTKi is a rare phenomenon except for CD49d-positive CLL mainly expressed in trisomy 12.

Luca Laurenti, Feliciana Guglielmi, Antonio Mosca

Pageof 12

Frequent Collaborators

15 joint publications

Riccardo Moia

11 joint publications

Samir Mouhssine

10 joint publications

Paolo Ghia

10 joint publications

Andrea Patriarca